SHOUCHENG Holdings has announced that a fund managed by its wholly-owned subsidiary, Shoucheng Capital, has invested in Chengguang Optics Technology (Nantong) Co., Ltd. This investment will significantly support the portfolio company in team building, product research and development, and iterative upgrades, helping it to continuously build core technological barriers. Chengguang Optics is a high-tech enterprise focused on developing label-free super-resolution imaging equipment for live cells based on Optical Diffraction Tomography (ODT) technology. Having collaborated with leading global manufacturers, the company represents an innovative force in breaking international monopolies in domestic high-end optical instruments. The investment will provide greater momentum for Chengguang Optics in areas such as team development and core industrial R&D, further accelerating the industrialization of its technology and building core technological advantages and market competitiveness. Moving forward, the group remains committed to increasing its investment in cutting-edge technologies. Leveraging its capital strength and industrial synergies, it aims to assist portfolio companies in commercializing scientific research outcomes, contributing to advancements in life sciences and the healthcare industry, and promoting the growth of high-end medical equipment and life science instruments.
Comments